The uptake of alpha-foetoprotein by C-1300 mouse neuroblastoma cells.

por Hajeri-Germond, M., Naval, J., Trojan, J., Uriel, J.
Publicado 1985

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

por Kullmann, F, Hollerbach, S, Dollinger, M M, Harder, J, Fuchs, M, Messmann, H, Trojan, J, Gäbele, E, Hinke, A, Hollerbach, C, Endlicher, E
Publicado 2009

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

por Nehls, O, Oettle, H, Hartmann, J T, Hofheinz, R-D, Hass, H G, Horger, M S, Koppenhöfer, U, Hochhaus, A, Stieler, J, Trojan, J, Gregor, M, Klump, B
Publicado 2008

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial

por Stocker, G., Lorenzen, S., Ettrich, T., Herz, A.-L., Longo, F., Kiani, A., Venerito, M., Trojan, J., Mahlberg, R., Moosmann, N., Chibaudel, B., Kubicka, S., Greil, R., Daum, S., Geissler, M., Larcher-Senn, J., Keller, G., Lordick, F., Haag, G.M.
Publicado 2023